Moldova vs Nepal: Statin use vs. average non-HDL cholesterol levels
Moldova
3.2
in 2018
Nepal
3.2
in 2018
Moldova rank
118th
Nepal rank
118th
Statin use vs. average non-HDL cholesterol levels over time
- Moldova
- Nepal
How they compare
Moldova currently reports 3.2 against 3.2 in Nepal, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Moldova ahead.
Moldova ranks 118th and Nepal ranks 118th of 191 countries.
Moldova has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Moldova | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.8 | 2.85 | 0.95 | Moldova |
| 1990s | 3.71 | 2.97 | 0.74 | Moldova |
| 2000s | 3.5 | 3.07 | 0.43 | Moldova |
| 2010s | 3.3 | 3.14 | 0.1556 | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Moldova or Nepal?
- Moldova, at 3.2 against 3.2 in Nepal as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Moldova and Nepal?
- 0, with Moldova ahead.
- How many years of comparable data are there for Moldova and Nepal?
- 39 years are reported by both, from 1980 to 2018.
- How do Moldova and Nepal rank globally for statin use vs. average non-hdl cholesterol levels?
- Moldova ranks 118th and Nepal ranks 118th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.